ZAMO', Alberto
 Distribuzione geografica
Continente #
NA - Nord America 5.094
EU - Europa 4.455
AS - Asia 1.726
SA - Sud America 19
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 4
Totale 11.317
Nazione #
US - Stati Uniti d'America 5.064
GB - Regno Unito 1.609
CN - Cina 1.281
IT - Italia 494
SE - Svezia 433
FR - Francia 416
RU - Federazione Russa 342
FI - Finlandia 315
DE - Germania 300
IE - Irlanda 279
SG - Singapore 262
UA - Ucraina 126
BE - Belgio 57
TR - Turchia 41
NL - Olanda 30
CA - Canada 26
VN - Vietnam 25
IR - Iran 20
IN - India 18
KR - Corea 18
JP - Giappone 16
AU - Australia 12
ES - Italia 11
IL - Israele 10
ID - Indonesia 8
CL - Cile 7
RO - Romania 7
CH - Svizzera 5
NP - Nepal 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 3
AR - Argentina 3
BG - Bulgaria 3
BR - Brasile 3
EE - Estonia 3
EU - Europa 3
HU - Ungheria 3
LU - Lussemburgo 3
LV - Lettonia 3
MX - Messico 3
PK - Pakistan 3
PY - Paraguay 3
BY - Bielorussia 2
EG - Egitto 2
HK - Hong Kong 2
IQ - Iraq 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
MY - Malesia 2
NO - Norvegia 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
CO - Colombia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 11.317
Città #
Southend 1.480
Jacksonville 990
Chandler 824
Woodbridge 524
Ann Arbor 466
Dublin 279
Houston 263
Ashburn 255
Beijing 241
Singapore 187
Wilmington 157
Lawrence 143
Princeton 143
Jinan 119
Nanjing 118
New York 94
Verona 92
Shenyang 90
Hebei 70
Sindelfingen 67
Helsinki 61
Brussels 57
Boardman 56
Tianjin 55
Nanchang 54
Ningbo 53
Haikou 41
Changsha 36
Milan 36
Zhengzhou 36
Jiaxing 33
Dearborn 32
Taizhou 32
Hangzhou 31
Taiyuan 26
Bologna 24
Fairfield 24
Norwalk 23
Los Angeles 21
Redmond 21
Guangzhou 20
Lancaster 20
Groningen 19
Falls Church 18
Rome 17
Seoul 17
Fuzhou 14
Redwood City 13
San Francisco 12
Chicago 11
Dallas 11
Düsseldorf 11
Kent 11
Leawood 11
Seattle 11
Dong Ket 10
Dongguan 10
Lanzhou 10
Toronto 10
Washington 10
Zanjan 10
Clearwater 9
Tokyo 9
Jakarta 8
Torino 8
Wuhan 8
Augusta 7
Cambridge 7
Catania 7
Paris 7
Châtenay-Malabry 6
Palermo 6
San Mateo 6
Amsterdam 5
Asiago 5
Auburn Hills 5
Hyderabad 5
Madrid 5
Parsa 5
Qingdao 5
San Diego 5
Verdun 5
Andover 4
Denver 4
Irving 4
Newark 4
Riva 4
Romola 4
San Jose 4
Trieste 4
Ardabil 3
Buenos Aires 3
Castelnuovo Rangone 3
Detroit 3
Frankfurt am Main 3
Hefei 3
Kochi 3
London 3
Lonigo 3
Luxembourg 3
Totale 7.825
Nome #
Leucemia linfatica cronica/linfoma linfocitico (LLC): l'espressione di ZAP-70, analizzata alla diagnosi su biopsia ossea, è un importante fattore prognostico 262
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 223
Espressione di TP73L nei linfomi B a grandi cellule primitivi del mediastino: un utile marcatore diagnostico 148
Chromium-induced diffuse dermatitis with lymph node involvement resulting from Langerhans cell histiocytosis after metal-on-metal hip resurfacing 144
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 144
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 134
Espressione di marcatori di migrazione e invasività nei foci fibroblastici nella fibrosi polmonare idiopatica 133
B-cell chronic lymphocytic leukemia cells espress functional death receptor 3 following stimulation of the B cell receptor 132
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 130
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 127
Detection of allele-specific gene expression on next generation sequencing data 121
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 119
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 118
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 116
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 114
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 113
CD10 is expressed in a subset of chromophobe renal cell carcinomas 112
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma. 112
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 111
slan+ monocytes and macrophages mediate CD20-dependent B cell lymphoma elimination via ADCC and ADCP 110
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 107
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 107
Establishment of the MAVER -1 cell line, a model for leukemic and aggressive mantle cell lymphoma. 107
Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypy 106
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 105
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 102
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis 100
Application of a commercial software to the analysis of infrared structural images on lymph node tissues: a preliminary study 100
Analysis of colorectal cancers for human cytomegalovirus presence 100
ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case 100
The role of disease causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. 96
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 96
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma. 95
Microfluidic Deletion/Insertion Analysis for Rapid Screening of KIT and PDGFRA Mutations in CD117-Positive Gastrointestinal Stromal Tumors: Diagnostic Applications and Report of a New KIT Mutation. 95
FPA micro spectral imaging of non-Hodgkin lymphomas 92
Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol: a proteomic analysis. 92
Use of a Chip-based microfluidic apparatus in the analytic step of the Biomed-2 protocol for the detection of B-cell clonality 91
Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours 90
GREY ZONES OF HODGKIN LYMPHOMA: REPORT OF A CASE WITH FEATURES INTERMEDIATE BETWEEN PRIMARY MEDIASTINAL B-CELL LYMPHOMA, CLASSICAL HODGKIN LYMPHOMA AND NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA 90
In Vitro and In Vivo Model of EBV-Positive Non-Hodgkin Plasmablastic Lymphoma with Focal Plasmacytic Differentiation 89
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 89
Evaluation of S-phase fraction as a prognostic marker in mantle cell lymphoma 88
A 6-GENE EXPRESSION SIGNATURE IN MANTLE CELL LYMPHOMA: RESULTS FROM THE FONDAZIONE ITALIANA LINFOMI (FIL)-MCL-0208 TRIAL 88
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 87
Tissue proteomics of splenic marginal zone lymphoma 87
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL". 87
Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis 87
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 86
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 86
An unusual case of sarcoidosis in an adult patient with sickle cell disease: Management with methotrexate and low dose of steroid 85
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 85
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 84
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 84
Haploidentical hematopoietic stem cell transplantation in a myelofibrosis patient with primary graft failure 84
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death 83
Resveratrol activity on MCL cell line jeko-1: a proteomic approach 83
VR09 Cell Line: An EBV-Positive Lymphoblastoid Cell Line with In Vivo Characteristics of Diffuse Large B Cell Lymphoma of Activated B-Cell Type 83
A Rare Disorder in an Orphan Disease: Kikuchi Fujimoto Disease in a Young-Adult Patient with Sickle Cell Anemia 83
Signal transduction pathways of mantle cell lymphoma: a phosphoproteome-based study. 83
Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas 82
Identification of the core phosphoproteome of mantle cell lymphoma cell lines 81
Application of Microfluidic Technology to the BIOMED-2 Protocol for Detection of B-Cell Clonality 81
Phosphoproteome profiling of mantle cell lymphoma cell lines 80
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathwayn as a potential therapeutic target 80
[Primary large B cell non-Hodgkin's lymphoma of the mediastinum] 80
Utilizzo di un apparato microfluidico per il rilevamento del riarrangiamento clonale dei geni delleimmunoglobuline secondo il protocollo BIOMED-2 79
Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. 79
Utilizzo dell'analisi microfluidica per il rilevamento di mutazioni dei geni KIT e PDGFRA nei tumori dello stroma gastroenterico. 78
CD16 expression in T-cell lymphomas: analysis on paraffin embedded tissues using the 2H7 antibody. 78
In reply to Schäfer et al: new evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma 78
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways 78
Activated KIT hyperexpression in thymic carcinoma: a potential target for therapeutic intervention. 77
PHOSPHOSCAN ANALYSIS OF MANTLE CELL LYMPHOMA CELL LINES 77
Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas 76
Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol : a proteomic analysis 74
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua 74
Metodi e tecniche dell'anatomia patologica 73
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathway as a potential therapeutic target. 73
Anaplastic large-cell lymphoma 73
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 72
Models for quantitative individual grading and prognosis in breast malignancies 71
Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer. 71
Stat3 and Ras activation are required for the cellular transformation mediated by NPM-ALK 70
Quantitative evaluation of differential expression of p63 isoforms in primary mediastinal B-cell lymphomas by real-time PCR 70
Application of a commercial software to the analysis of infrared spectral images on lymph node tissues: a preliminary study. 70
Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12. 67
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. 66
ALK-mediated activation of STAT3 elicits growth and anti-apoptotic signals. 66
Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis 65
TCL1A expression in marginal zone lymphoma: a clinico-pathological evaluation in paired spleen and bone marrow samples 65
VDJSeq-Solver: In Silico V(D)J Recombination Detection Tool 65
Expression of c-kit and activated c-kit (phospho c-kit) in thymic carcinomas and WHO type B3 thymomas 64
Anaplastic lymphoma kinase in human cancer 64
Proteomic characterization of two mantle cell lymphoma cell lines 63
The Who Classification of Lymphomas of the Mediastinum: Pathology and Genetics 63
Stat3 and Ras activation are required for the cellular transformation mediated by NPM-ALK. 63
Linfomi non-Hodgkin B ALK+ 62
p53-p63 cross-talk in lymphomas 62
Identification of a three-gene model as a powerful diagnostic tool for the recognition of ALK negative ALCL 62
Impacts: planning a European initiative for standardized protein analysis of archival clinical tissues 62
Totale 9.239
Categoria #
all - tutte 37.159
article - articoli 20.104
book - libri 0
conference - conferenze 16.435
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 620
Totale 74.318


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.198 0 0 0 114 127 210 141 131 59 145 86 185
2020/20211.310 96 230 65 147 162 140 17 95 89 20 202 47
2021/20221.198 99 398 5 96 44 28 13 76 47 41 105 246
2022/20232.380 174 241 248 438 223 523 16 141 275 20 53 28
2023/20241.095 59 102 78 145 132 178 42 74 15 48 146 76
2024/2025636 135 230 87 184 0 0 0 0 0 0 0 0
Totale 11.441